Loading...

JSTL Jeevan Scientific Technology Ltd Capital Structure Changes Announcement

Jvn

JSTL

Jeevan Scientific Technology Ltd

(JSTL)

2026 Announcement

Board Meeting Intimation

Regulatory Compliance

Initial Disclosure

Regulatory Compliance Certi...

SAST disclosure

Regulatory Compliance

Trading window closure

Unaudited financials

US FDA Remote Assessment

Regulatory Compliance

SEBI SAST Disclosure

Regulatory disclosure

Regulatory Disclosure (SAST)

Regulatory disclosure

SAST disclosure

Regulation 29(2) disclosure

Preferential issue disclosure

SEBI SAST disclosure

Reg 29(1 disclosure)

Preferential Allotment

Regulatory disclosure under...

Preferential allotment

SAST Disclosure

Regulatory disclosure under...

Board meeting postponement

Trading Window Closure

Preferential allotment

Asset Acquisition

Standalone and Consolidated

Board meeting outcome

Board Meeting Notice

FDA Evaluation Complete

Compliance Certificate

Preferential Issue

Board Meeting Outcome

Director Retirement

Director Resignation

Management Changes

Board Meeting Postponed

Compliance Certificate

Financial Results Published

Annual Compliance Report

Management Change

Regulatory Compliance

Successful CDSCO Inspection

Newspaper Publication

Financial Results Published

Financial Results Q3

New CFO Appointment

Compliance Confirmation

CFO Resignation

Financial Results Update

Management Changes

Regulatory Compliance

Financial Results Publication

Newspaper Advertisement

Compliance Certificate Subm...

Approval Received

Financial Results Publication

Financial Results and Manag...

Compliance Submission

Compliance Certificate

Compliance Certificate

Compliance Certificate Subm...

Successful Inspection

Publication of Financial Re...

Compliance Certificate Subm...

Financial Results

Co-Development Agreement

Compliance Certificate

Newspaper Publication

Closure of US FDA Remote Re...

Financial Statements

Appointments, Resignations

Compliance Certificate Subm...

Regulatory Inspection Closure

Earnings Releases

External Links:

Data:

Board approves preferential issue of warrants and equity shares to promoters and non-promoters, with 25% upfront; total potential proceeds around ₹30.34 crore upon full exercise.

AI Assistant

Jeevan Scientific Technology Ltd

2026

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.